Blueprint
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): March 12,
2019
UNITED STATES ANTIMONY CORPORATION
|
(Exact name of registrant as specified in its charter)
|
Montana
|
33-00215
|
81-0305822
|
(State or other jurisdiction
|
(Commission File Number)
|
(IRS Employer Identification No.)
|
of incorporation)
|
|
|
P.O.
Box 643
Thompson Falls, Montana
|
59873
|
(Address
of principal executive offices)
|
(Zip
Code)
|
Registrant’s telephone number, including
area code: (406)
827-3523
Not Applicable
|
(Former name or former address, if changed since last
report.)
|
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
[ ] Written communications pursuant to Rule 425 under the
Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange
Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under
the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under
the Exchange Act (17 CFR 240.13e-4(c))
Item 5.02 Departure of Directors or Certain Officers; Election of
Directors; Appointment of Certain Officers; Compensatory
Arrangements of Certain Officers .
On
March 12, 2019, Gary D Babbitt resigned as a director of United
States Antimony Corporation, or the Company, for medical reasons.
Mr. Babbitt joined the Company’s Board in 1998, and served on
the Executive, Audit, and Compensation Committees of the board of
directors.
On
March 14, 2019, Whitney H. Ferer resigned as a director of the
Company, again for medical reasons. Mr. Ferer joined the
Company’s Board in 2012, and served on the Audit,
Compensation, and Corporate Governance and Nominating Committees of
the board of directors.
With
the resignation of Messrs. Babbitt and Ferer, the Company has five
directors, three of whom are independent directors as required by
the rules of the NYSE American exchange.
SIGNATURES
Pursuant to the
requirements of the Securities Exchange Act of 1934, the Registrant
has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Date:
March 15, 2019
UNITED
STATES ANTIMONY CORPORATION
John C.
Lawrence
President, Director
and Principal Executive Office